US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Verrica Pharmaceuticals Inc.

4.52

-0.2800-5.84%

Post-market: 4.520.00000.00%16:10 EDT

Volume:54.55K

Turnover:255.13K

Market Cap:77.56M

PE:-2.59

High:4.85

Open:4.85

Low:4.52

Close:4.80

52wk High:9.82

52wk Low:3.28

Shares:17.18M

Float Shares:6.78M

Volume Ratio:1.35

T/O Rate:0.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.7400

EPS(LYR):-1.6791

ROE:-240.35%

ROA:-43.98%

PB:18.01

PE(LYR):-2.69

Loading ...

Overview Company News Filings

Verrica Pharmaceuticals Schedules Conference Call to Discuss Q2 Results, Corporate Update

Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

THOMSON REUTERS

Verrica Signs Exclusive Deal with Medomie to Market Ycanth in Israel

Verrica Pharmaceuticals: Granted Medomie Exclusive Right to Obtain & Maintain Marketing Authorizations for Ycanth in Israel

THOMSON REUTERS

Verrica Pharmaceuticals Inc: Eligible to Receive up to $8.2 Mln in Total Regulatory and Commercial Milestones

THOMSON REUTERS

Verrica Pharmaceuticals Inc: Will Receive 60% of Net Selling Price of Product Sold by Medomie in Israel

THOMSON REUTERS

Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize Ycanth® for the Treatment of Molluscum Contagiosum in Israel

THOMSON REUTERS

Verrica Pharmaceuticals' Doses First US Patient in Phase 3 Trial Evaluating Ycanth to Treat Common Warts

MT Newswires Live

Verrica doses first US patient in pivotal Phase 3 COVE-3 trial of YCANTH for common warts

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (Cove-3) of Its Phase 3 Program Evaluating Ycanth® (Vp-102) for the Treatment of Common Warts

THOMSON REUTERS

Verrica’s COVE-3 Wart Study Moves Forward, Offering a Small but Notable Catalyst for VRCA and VEEV

Verrica Pharmaceuticals shareholders approve amended 2018 equity incentive plan at annual meeting

Verrica Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy

Verrica Pharmaceuticals Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $12

THOMSON REUTERS

Lytix Biopharma Q1 net loss widens to NOK 25.95 million

Verrica Pharmaceuticals (VRCA) Returns To Larger Q1 Loss Challenging Bullish Profitability Narratives

Simply Wall St.

Verrica Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand

Verrica Q1 FY26 net loss flat at $9.7 million; revenue rises 46.1% YoY to $5 million

Verrica Pharmaceuticals Q1 Adj. EPS $(0.41) Misses $(0.38) Estimate, Sales $5.023M Beat $4.520M Estimate

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/VRCA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VRCA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCA\",,,,,undefined,":{"symbol":"VRCA","market":"US","secType":"STK","nameCN":"Verrica Pharmaceuticals Inc.","latestPrice":4.515,"timestamp":1790884800000,"preClose":4.795,"halted":0,"volume":54545,"hourTrading":{"tag":"盘后","latestPrice":4.515,"preClose":4.515,"latestTime":"16:10 EDT","volume":4,"amount":18.06,"timestamp":1790885404403,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05839416058394166,"floatShares":6777400,"shares":17178800,"eps":-1.74,"marketStatus":"Post-Mkt","change":-0.28,"latestTime":"10-01 18:50:30 EDT","open":4.85,"high":4.85,"low":4.515,"amount":255127,"amplitude":0.069864,"askPrice":5.16,"askSize":100,"bidPrice":4.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.74,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1529035200000,"exchange":"NASDAQ","adjPreClose":4.795,"preHourTrading":{"tag":"盘前","latestPrice":4.9,"preClose":4.795,"latestTime":"04:39 EDT","volume":71,"amount":352.90001170000005,"timestamp":1790843989392,"change":0.105,"changeRate":0.021898,"amplitude":0.020855},"postHourTrading":{"tag":"盘后","latestPrice":4.515,"preClose":4.515,"latestTime":"16:10 EDT","volume":4,"amount":18.06,"timestamp":1790885404403,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.351161,"impliedVol":1.2061,"impliedVolPercentile":0.3},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VRCA\",,,,,undefined,":{"symbol":"VRCA","floatShares":6777400,"roa":"-43.98%","roe":"-240.35%","lyrEps":-1.679063,"volumeRatio":1.351161,"shares":17178800,"dividePrice":0,"high":4.85,"amplitude":0.069864,"preClose":4.795,"low":4.515,"week52Low":3.28,"pbRate":"18.01","psRate":"2.56","week52High":9.8212,"institutionHeld":0,"latestPrice":4.515,"eps":-1.74,"divideRate":0,"volume":54545,"delay":0,"ttmEps":-1.74,"open":4.85,"prevYearClose":8.31,"prevWeekClose":4.37,"prevMonthClose":4.795,"prevQuarterClose":4.795,"fiveDayClose":4.36,"twentyDayClose":5.39,"sixtyDayClose":6.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VRCA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"VRCA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.54},{"market":"US","date":"2026-05-12","symbol":"VRCA","fiscalQuarterEnding":"2026/03","expectedEps":-0.6,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.45},{"market":"US","date":"2026-03-11","symbol":"VRCA","fiscalQuarterEnding":"2025/12","expectedEps":-0.44,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773201600000,"reportTimeType":"pre","actualEps":-0.56},{"date":"2025-11-14","symbol":"VRCA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post-Mkt","dateTimestamp":1763096400000,"actualEps":null},{"market":"US","date":"2025-08-12","symbol":"VRCA","fiscalQuarterEnding":"2025/06","expectedEps":-0.7,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VRCA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VRCA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.7143,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1787889600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VRCA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VRCA","date":"2026-09-30","current":-2.755747,"percent":0.704156,"low":-13.801958,"twenty":-6.765011,"median":-4.254247,"eighty":-0.951885,"high":-0.377883,"avg":-4.516757,"sd":3.233026,"marketCap":76617385},"quantilePoints":[{"date":"2021-10-01","current":-9.515374,"twenty":-17.715526,"median":-10.222565,"eighty":-8.233156,"marketCap":344209147},{"date":"2021-10-08","current":-9.439312,"twenty":-17.573802,"median":-10.190534,"eighty":-8.247819,"marketCap":341457675},{"date":"2021-10-15","current":-10.161902,"twenty":-17.520656,"median":-10.161902,"eighty":-8.254927,"marketCap":367596659},{"date":"2021-10-22","current":-9.713136,"twenty":-17.006905,"median":-10.125651,"eighty":-8.256454,"marketCap":351362974},{"date":"2021-10-29","current":-9.576224,"twenty":-16.210213,"median":-10.103591,"eighty":-8.274702,"marketCap":346410324},{"date":"2021-11-05","current":-10.017384,"twenty":-16.174276,"median":-10.087097,"eighty":-8.28783,"marketCap":362368862},{"date":"2021-11-12","current":-8.809355,"twenty":-16.065695,"median":-10.077527,"eighty":-8.288551,"marketCap":339309923},{"date":"2021-11-19","current":-8.173481,"twenty":-16.06081,"median":-10.059534,"eighty":-8.28783,"marketCap":314817966},{"date":"2021-11-26","current":-7.473305,"twenty":-15.941288,"median":-10.041766,"eighty":-8.253505,"marketCap":287849294},{"date":"2021-12-03","current":-6.615947,"twenty":-15.702243,"median":-10.020775,"eighty":-8.1726,"marketCap":254826430},{"date":"2021-12-10","current":-6.987469,"twenty":-15.573376,"median":-10.010115,"eighty":-8.159756,"marketCap":269136338},{"date":"2021-12-17","current":-6.501633,"twenty":-15.554232,"median":-10.002172,"eighty":-8.101396,"marketCap":250423382},{"date":"2021-12-23","current":-6.737406,"twenty":-15.545879,"median":-9.957163,"eighty":-8.078665,"marketCap":259504669},{"date":"2021-12-31","current":-6.5445,"twenty":-15.404401,"median":-9.905662,"eighty":-8.050103,"marketCap":252074525},{"date":"2022-01-07","current":-6.480199,"twenty":-15.306325,"median":-9.880472,"eighty":-8.005508,"marketCap":249597810},{"date":"2022-01-14","current":-5.94435,"twenty":-15.155456,"median":-9.873556,"eighty":-7.967,"marketCap":228958520},{"date":"2022-01-21","current":-5.537105,"twenty":-15.045894,"median":-9.865313,"eighty":-7.935851,"marketCap":213272660},{"date":"2022-01-28","current":-5.43708,"twenty":-15.02557,"median":-9.832701,"eighty":-7.874921,"marketCap":209419993},{"date":"2022-02-04","current":-5.587117,"twenty":-15.00857,"median":-9.792473,"eighty":-7.845703,"marketCap":215198994},{"date":"2022-02-11","current":-5.887193,"twenty":-14.96848,"median":-9.783278,"eighty":-7.809671,"marketCap":226756996},{"date":"2022-02-18","current":-5.644274,"twenty":-14.936962,"median":-9.765677,"eighty":-7.717235,"marketCap":217400518},{"date":"2022-02-25","current":-5.758589,"twenty":-14.896984,"median":-9.762103,"eighty":-7.561149,"marketCap":221803567},{"date":"2022-03-04","current":-6.38555,"twenty":-14.755152,"median":-9.755823,"eighty":-7.515219,"marketCap":224005091},{"date":"2022-03-11","current":-6.181589,"twenty":-14.745783,"median":-9.737752,"eighty":-7.481244,"marketCap":216850137},{"date":"2022-03-18","current":-6.754249,"twenty":-14.723661,"median":-9.713136,"eighty":-7.424792,"marketCap":236939046},{"date":"2022-03-25","current":-6.542443,"twenty":-14.660984,"median":-9.687818,"eighty":-7.341298,"marketCap":229508902},{"date":"2022-04-01","current":-6.652268,"twenty":-14.645285,"median":-9.674618,"eighty":-7.270396,"marketCap":233361569},{"date":"2022-04-08","current":-6.887608,"twenty":-14.640589,"median":-9.665964,"eighty":-7.202806,"marketCap":241617285},{"date":"2022-04-14","current":-6.212967,"twenty":-14.637019,"median":-9.648308,"eighty":-7.123217,"marketCap":217950899},{"date":"2022-04-22","current":-5.726599,"twenty":-14.637019,"median":-9.621861,"eighty":-7.033623,"marketCap":200889086},{"date":"2022-04-29","current":-5.153939,"twenty":-14.480326,"median":-9.575546,"eighty":-7.002293,"marketCap":180800178},{"date":"2022-05-06","current":-4.816619,"twenty":-14.461891,"median":-9.561011,"eighty":-6.987469,"marketCap":168966985},{"date":"2022-05-13","current":-3.655086,"twenty":-14.438154,"median":-9.538384,"eighty":-6.96313,"marketCap":155757839},{"date":"2022-05-20","current":-3.835903,"twenty":-14.425022,"median":-9.508724,"eighty":-6.931361,"marketCap":163463174},{"date":"2022-05-27","current":-1.29155,"twenty":-14.39737,"median":-9.496783,"eighty":-6.895453,"marketCap":55038106},{"date":"2022-06-03","current":-1.465909,"twenty":-14.373536,"median":-9.485685,"eighty":-6.879432,"marketCap":62468250},{"date":"2022-06-10","current":-1.356127,"twenty":-14.325047,"median":-9.469488,"eighty":-6.861307,"marketCap":57790011},{"date":"2022-06-17","current":-1.452994,"twenty":-14.292293,"median":-9.460652,"eighty":-6.808853,"marketCap":61917869},{"date":"2022-06-24","current":-1.362585,"twenty":-14.264642,"median":-9.453534,"eighty":-6.788739,"marketCap":58065201},{"date":"2022-07-01","current":-2.012398,"twenty":-14.233303,"median":-9.439312,"eighty":-6.769114,"marketCap":85756345},{"date":"2022-07-08","current":-3.199435,"twenty":-14.196357,"median":-9.43704,"eighty":-6.737867,"marketCap":136340732},{"date":"2022-07-15","current":-3.095506,"twenty":-14.146545,"median":-9.427646,"eighty":-6.720845,"marketCap":131911910},{"date":"2022-07-22","current":-2.98943,"twenty":-14.126383,"median":-9.420826,"eighty":-6.650804,"marketCap":127391564},{"date":"2022-07-29","current":-3.037646,"twenty":-14.11343,"median":-9.393106,"eighty":-6.6457,"marketCap":129446266},{"date":"2022-08-05","current":-3.259443,"twenty":-14.098659,"median":-9.386069,"eighty":-6.629464,"marketCap":138897899},{"date":"2022-08-12","current":-4.048576,"twenty":-14.089457,"median":-9.372181,"eighty":-6.615947,"marketCap":166019974},{"date":"2022-08-19","current":-3.407218,"twenty":-14.080212,"median":-9.36325,"eighty":-6.60378,"marketCap":139719780},{"date":"2022-08-26","current":-3.707855,"twenty":-14.074766,"median":-9.323537,"eighty":-6.587248,"marketCap":152047996},{"date":"2022-09-02","current":-3.948364,"twenty":-14.072368,"median":-9.298233,"eighty":-6.568162,"marketCap":161910568},{"date":"2022-09-09","current":-4.108704,"twenty":-14.068127,"median":-9.293402,"eighty":-6.548507,"marketCap":168485617},{"date":"2022-09-16","current":-3.607642,"twenty":-14.065549,"median":-9.287796,"eighty":-6.536167,"marketCap":147938590},{"date":"2022-09-23","current":-2.886114,"twenty":-14.063705,"median":-9.273837,"eighty":-6.523501,"marketCap":118350872},{"date":"2022-09-30","current":-2.926199,"twenty":-14.054478,"median":-9.269303,"eighty":-6.510959,"marketCap":119994634},{"date":"2022-10-07","current":-2.435159,"twenty":-14.038958,"median":-9.256763,"eighty":-6.47805,"marketCap":99858548},{"date":"2022-10-14","current":-2.735795,"twenty":-14.005422,"median":-9.237861,"eighty":-6.42674,"marketCap":112186764},{"date":"2022-10-21","current":-2.405095,"twenty":-13.997341,"median":-9.233944,"eighty":-6.407981,"marketCap":98625727},{"date":"2022-10-28","current":-2.425137,"twenty":-13.971532,"median":-9.225586,"eighty":-6.34789,"marketCap":99447608},{"date":"2022-11-04","current":-2.294861,"twenty":-13.919916,"median":-9.203519,"eighty":-6.323973,"marketCap":94105381},{"date":"2022-11-11","current":-3.45193,"twenty":-13.888612,"median":-9.197563,"eighty":-6.255329,"marketCap":96981965},{"date":"2022-11-18","current":-3.539691,"twenty":-13.879534,"median":-9.165488,"eighty":-6.211558,"marketCap":99447608},{"date":"2022-11-25","current":-3.788347,"twenty":-13.872169,"median":-9.151804,"eighty":-6.15021,"marketCap":106433597},{"date":"2022-12-02","current":-4.914612,"twenty":-13.871986,"median":-9.14739,"eighty":-6.10155,"marketCap":138076018},{"date":"2022-12-09","current":-4.519688,"twenty":-13.837527,"median":-9.128958,"eighty":-6.040385,"marketCap":126980623},{"date":"2022-12-16","current":-4.344166,"twenty":-13.816682,"median":-9.113473,"eighty":-6.010411,"marketCap":122049337},{"date":"2022-12-23","current":-3.671332,"twenty":-13.816682,"median":-9.097752,"eighty":-5.987218,"marketCap":103146073},{"date":"2022-12-30","current":-4.022376,"twenty":-13.809189,"median":-9.072206,"eighty":-5.975782,"marketCap":113008645},{"date":"2023-01-06","current":-5.675206,"twenty":-13.790814,"median":-9.048839,"eighty":-5.963696,"marketCap":159444925},{"date":"2023-01-13","current":-7.094008,"twenty":-13.774283,"median":-9.048276,"eighty":-5.966499,"marketCap":199306157},{"date":"2023-01-20","current":-6.070131,"twenty":-13.766909,"median":-9.029872,"eighty":-5.967544,"marketCap":170540319},{"date":"2023-01-27","current":-6.889233,"twenty":-13.761379,"median":-9.007347,"eighty":-5.972089,"marketCap":193552989},{"date":"2023-02-03","current":-7.664454,"twenty":-13.754146,"median":-8.998696,"eighty":-5.979662,"marketCap":215332837},{"date":"2023-02-10","current":-10.385043,"twenty":-13.739615,"median":-8.99924,"eighty":-5.983253,"marketCap":291767776},{"date":"2023-02-17","current":-11.584442,"twenty":-13.733946,"median":-9.009597,"eighty":-5.985324,"marketCap":325464899},{"date":"2023-02-24","current":-11.974593,"twenty":-13.731884,"median":-9.029872,"eighty":-5.987218,"marketCap":336426186},{"date":"2023-03-03","current":-10.73841,"twenty":-13.720823,"median":-9.048668,"eighty":-5.990491,"marketCap":301695622},{"date":"2023-03-10","current":-11.21205,"twenty":-13.704314,"median":-9.057958,"eighty":-6.004597,"marketCap":274549467},{"date":"2023-03-17","current":-11.998261,"twenty":-13.69687,"median":-9.078186,"eighty":-6.009004,"marketCap":293801412},{"date":"2023-03-24","current":-11.160775,"twenty":-13.691896,"median":-9.102099,"eighty":-6.013181,"marketCap":273293906},{"date":"2023-03-31","current":-11.109501,"twenty":-13.676811,"median":-9.124348,"eighty":-6.024347,"marketCap":272038344},{"date":"2023-04-06","current":-10.340381,"twenty":-13.670364,"median":-9.142652,"eighty":-6.024696,"marketCap":253204920},{"date":"2023-04-14","current":-10.76767,"twenty":-13.669206,"median":-9.149196,"eighty":-6.03254,"marketCap":263667933},{"date":"2023-04-21","current":-10.528388,"twenty":-13.650772,"median":-9.161388,"eighty":-6.040385,"marketCap":257808646},{"date":"2023-04-28","current":-10.135283,"twenty":-13.633013,"median":-9.181896,"eighty":-6.062388,"marketCap":248182674},{"date":"2023-05-05","current":-10.955677,"twenty":-13.632835,"median":-9.201925,"eighty":-6.062388,"marketCap":268271659},{"date":"2023-05-12","current":-11.756195,"twenty":-13.632337,"median":-9.224245,"eighty":-6.070131,"marketCap":265760536},{"date":"2023-05-19","current":-10.97862,"twenty":-13.62363,"median":-9.232771,"eighty":-6.093505,"marketCap":248182674},{"date":"2023-05-26","current":-10.849024,"twenty":-13.620563,"median":-9.234057,"eighty":-6.10155,"marketCap":245253030},{"date":"2023-06-02","current":-10.552805,"twenty":-13.615653,"median":-9.247013,"eighty":-6.114083,"marketCap":238556702},{"date":"2023-06-09","current":-10.552805,"twenty":-13.614007,"median":-9.264369,"eighty":-6.118509,"marketCap":238556702},{"date":"2023-06-16","current":-11.608085,"twenty":-13.590351,"median":-9.271821,"eighty":-6.127261,"marketCap":262412372},{"date":"2023-06-23","current":-11.348893,"twenty":-13.555269,"median":-9.269303,"eighty":-6.124452,"marketCap":256553084},{"date":"2023-06-30","current":-10.663887,"twenty":-13.492373,"median":-9.266785,"eighty":-6.121642,"marketCap":241067825},{"date":"2023-07-07","current":-10.793483,"twenty":-13.458555,"median":-9.266785,"eighty":-6.121642,"marketCap":243997468},{"date":"2023-07-14","current":-12.792961,"twenty":-13.409279,"median":-9.266785,"eighty":-6.121642,"marketCap":289197686},{"date":"2023-07-21","current":-13.292831,"twenty":-13.327224,"median":-9.266785,"eighty":-6.121642,"marketCap":300497740},{"date":"2023-07-28","current":-9.590093,"twenty":-13.290873,"median":-9.266785,"eighty":-6.121642,"marketCap":216793634},{"date":"2023-08-04","current":-9.849284,"twenty":-13.221364,"median":-9.266785,"eighty":-6.121642,"marketCap":222652921},{"date":"2023-08-11","current":-9.581818,"twenty":-13.103509,"median":-9.264369,"eighty":-6.121642,"marketCap":224482838},{"date":"2023-08-18","current":-8.220663,"twenty":-13.051899,"median":-9.23417,"eighty":-6.121642,"marketCap":192593687},{"date":"2023-08-25","current":-7.808734,"twenty":-12.975777,"median":-9.224924,"eighty":-6.121642,"marketCap":182943023},{"date":"2023-09-01","current":-8.149023,"twenty":-12.885999,"median":-9.197563,"eighty":-6.121642,"marketCap":190915310},{"date":"2023-09-08","current":-7.486355,"twenty":-12.87598,"median":-9.161388,"eighty":-6.121642,"marketCap":175390329},{"date":"2023-09-15","current":-7.540085,"twenty":-12.821585,"median":-9.142652,"eighty":-6.121642,"marketCap":176649111},{"date":"2023-09-22","current":-6.716228,"twenty":-12.731741,"median":-9.099561,"eighty":-6.121642,"marketCap":157347783},{"date":"2023-09-29","current":-6.805777,"twenty":-12.614132,"median":-9.06243,"eighty":-6.121642,"marketCap":159445754},{"date":"2023-10-06","current":-7.056517,"twenty":-12.464757,"median":-9.042033,"eighty":-6.118832,"marketCap":165320071},{"date":"2023-10-13","current":-6.537128,"twenty":-12.44537,"median":-8.99924,"eighty":-6.118832,"marketCap":153151842},{"date":"2023-10-20","current":-6.340119,"twenty":-12.38566,"median":-8.968705,"eighty":-6.118832,"marketCap":148536307},{"date":"2023-10-27","current":-6.286389,"twenty":-12.188778,"median":-8.921666,"eighty":-6.117862,"marketCap":147277525},{"date":"2023-11-03","current":-7.092336,"twenty":-12.124264,"median":-8.88076,"eighty":-6.107816,"marketCap":166159259},{"date":"2023-11-10","current":-2.787856,"twenty":-12.053336,"median":-8.855019,"eighty":-6.079481,"marketCap":134689702},{"date":"2023-11-17","current":-3.021216,"twenty":-11.974282,"median":-8.823841,"eighty":-6.033784,"marketCap":145963998},{"date":"2023-11-24","current":-3.291123,"twenty":-11.946973,"median":-8.809355,"eighty":-6.009356,"marketCap":159004010},{"date":"2023-12-01","current":-3.204056,"twenty":-11.792001,"median":-8.772232,"eighty":-5.983253,"marketCap":154797555},{"date":"2023-12-08","current":-3.491376,"twenty":-11.680352,"median":-8.755058,"eighty":-5.963696,"marketCap":168678857},{"date":"2023-12-15","current":-3.273709,"twenty":-11.5949,"median":-8.746737,"eighty":-5.94435,"marketCap":158162719},{"date":"2023-12-22","current":-5.580978,"twenty":-11.531982,"median":-8.733866,"eighty":-5.919137,"marketCap":269633784},{"date":"2023-12-29","current":-6.347165,"twenty":-11.481358,"median":-8.726015,"eighty":-5.897703,"marketCap":306650591},{"date":"2024-01-05","current":-5.833471,"twenty":-11.456718,"median":-8.705341,"eighty":-5.887193,"marketCap":281832505},{"date":"2024-01-12","current":-5.180471,"twenty":-11.382196,"median":-8.657402,"eighty":-5.847771,"marketCap":250284090},{"date":"2024-01-19","current":-5.015044,"twenty":-11.319267,"median":-8.629782,"eighty":-5.815746,"marketCap":242291825},{"date":"2024-01-26","current":-4.927977,"twenty":-11.292577,"median":-8.600502,"eighty":-5.780023,"marketCap":238085369},{"date":"2024-02-02","current":-5.006337,"twenty":-11.199619,"median":-8.585761,"eighty":-5.716494,"marketCap":241871179},{"date":"2024-02-09","current":-4.562297,"twenty":-11.157999,"median":-8.553331,"eighty":-5.660612,"marketCap":220418257},{"date":"2024-02-16","current":-4.840911,"twenty":-11.109501,"median":-8.520481,"eighty":-5.582206,"marketCap":233878914},{"date":"2024-02-23","current":-4.44911,"twenty":-11.107206,"median":-8.503948,"eighty":-5.531389,"marketCap":214949865},{"date":"2024-03-01","current":-3.308907,"twenty":-11.065253,"median":-8.450504,"eighty":-5.425178,"marketCap":221680194},{"date":"2024-03-08","current":-3.077158,"twenty":-11.026791,"median":-8.406267,"eighty":-5.308737,"marketCap":206154167},{"date":"2024-03-15","current":-3.102484,"twenty":-11.012924,"median":-8.370716,"eighty":-5.206723,"marketCap":207850909},{"date":"2024-03-22","current":-3.197458,"twenty":-10.980747,"median":-8.337022,"eighty":-5.168824,"marketCap":214213692},{"date":"2024-03-28","current":-3.577354,"twenty":-10.949764,"median":-8.293845,"eighty":-5.133489,"marketCap":239664824},{"date":"2024-04-05","current":-4.064887,"twenty":-10.882731,"median":-8.255691,"eighty":-5.042905,"marketCap":272327110},{"date":"2024-04-12","current":-4.476441,"twenty":-10.811536,"median":-8.192932,"eighty":-4.983583,"marketCap":299899169},{"date":"2024-04-19","current":-4.368958,"twenty":-10.781343,"median":-8.156467,"eighty":-4.929718,"marketCap":292698365},{"date":"2024-04-26","current":-4.210663,"twenty":-10.745711,"median":-8.101591,"eighty":-4.905516,"marketCap":282093352},{"date":"2024-05-03","current":-4.280313,"twenty":-10.672045,"median":-8.073894,"eighty":-4.840911,"marketCap":286759558},{"date":"2024-05-10","current":-4.96415,"twenty":-10.664627,"median":-8.044877,"eighty":-4.817379,"marketCap":332573215},{"date":"2024-05-17","current":-4.807504,"twenty":-10.664627,"median":-8.011574,"eighty":-4.801428,"marketCap":388143484},{"date":"2024-05-24","current":-4.387176,"twenty":-10.664627,"median":-7.970027,"eighty":-4.742525,"marketCap":354207442},{"date":"2024-05-31","current":-4.376668,"twenty":-10.664627,"median":-7.943413,"eighty":-4.651329,"marketCap":353359041},{"date":"2024-06-07","current":-4.613103,"twenty":-10.664627,"median":-7.943413,"eighty":-4.601414,"marketCap":372448065},{"date":"2024-06-14","current":-4.497512,"twenty":-10.664874,"median":-7.900245,"eighty":-4.564052,"marketCap":363115653},{"date":"2024-06-21","current":-3.788208,"twenty":-10.665121,"median":-7.849613,"eighty":-4.534314,"marketCap":305848582},{"date":"2024-06-28","current":-3.793463,"twenty":-10.66865,"median":-7.826644,"eighty":-4.519134,"marketCap":306272782},{"date":"2024-07-05","current":-3.940577,"twenty":-10.650054,"median":-7.808919,"eighty":-4.508021,"marketCap":318150397},{"date":"2024-07-12","current":-4.45548,"twenty":-10.602867,"median":-7.747352,"eighty":-4.497512,"marketCap":359722049},{"date":"2024-07-15","current":-4.476496,"twenty":-10.596755,"median":-7.7222,"eighty":-4.497512,"marketCap":361418851},{"date":"2024-08-02","current":-3.325847,"twenty":-10.578207,"median":-7.559041,"eighty":-4.474894,"marketCap":268518935},{"date":"2024-08-09","current":-2.700609,"twenty":-10.578207,"median":-7.511408,"eighty":-4.445712,"marketCap":218039072},{"date":"2024-08-16","current":-1.428289,"twenty":-10.578207,"median":-7.48442,"eighty":-4.417713,"marketCap":124165489},{"date":"2024-08-23","current":-1.369391,"twenty":-10.578207,"median":-7.414715,"eighty":-4.368398,"marketCap":119045262},{"date":"2024-08-30","current":-1.197604,"twenty":-10.578207,"median":-7.31913,"eighty":-4.342793,"marketCap":104111269},{"date":"2024-09-06","current":-1.020908,"twenty":-10.578207,"median":-7.268599,"eighty":-4.299308,"marketCap":88750590},{"date":"2024-09-13","current":-0.952193,"twenty":-10.57053,"median":-7.199796,"eighty":-4.265299,"marketCap":82776992},{"date":"2024-09-20","current":-0.952193,"twenty":-10.552805,"median":-7.163976,"eighty":-4.203283,"marketCap":82776992},{"date":"2024-09-27","current":-0.824579,"twenty":-10.525337,"median":-7.123217,"eighty":-4.090084,"marketCap":71683169},{"date":"2024-10-04","current":-0.711691,"twenty":-10.4973,"median":-7.056517,"eighty":-4.042507,"marketCap":61869401},{"date":"2024-10-11","current":-0.633159,"twenty":-10.414401,"median":-7.005278,"eighty":-3.999567,"marketCap":55042433},{"date":"2024-10-18","current":-0.716599,"twenty":-10.343336,"median":-6.99446,"eighty":-3.935721,"marketCap":62296087},{"date":"2024-10-25","current":-0.736232,"twenty":-10.290696,"median":-6.962367,"eighty":-3.916296,"marketCap":64002829},{"date":"2024-10-31","current":-0.785314,"twenty":-10.224124,"median":-6.939632,"eighty":-3.906623,"marketCap":68269684},{"date":"2024-11-08","current":-0.377883,"twenty":-10.16594,"median":-6.892343,"eighty":-3.872942,"marketCap":32116639},{"date":"2024-11-15","current":-0.463192,"twenty":-10.108795,"median":-6.877417,"eighty":-3.82734,"marketCap":39367166},{"date":"2024-11-22","current":-0.531171,"twenty":-10.076692,"median":-6.861307,"eighty":-3.788291,"marketCap":45144787},{"date":"2024-11-29","current":-1.363944,"twenty":-10.008707,"median":-6.82911,"eighty":-3.748307,"marketCap":115922995},{"date":"2024-12-06","current":-1.129516,"twenty":-9.958444,"median":-6.798296,"eighty":-3.687233,"marketCap":95998730},{"date":"2024-12-13","current":-0.855236,"twenty":-9.882798,"median":-6.779649,"eighty":-3.610752,"marketCap":72687340},{"date":"2024-12-20","current":-0.720653,"twenty":-9.865302,"median":-6.743758,"eighty":-3.581084,"marketCap":61249001},{"date":"2024-12-27","current":-0.691243,"twenty":-9.849284,"median":-6.732995,"eighty":-3.514038,"marketCap":58749411},{"date":"2025-01-03","current":-0.748678,"twenty":-9.806688,"median":-6.710314,"eighty":-3.484906,"marketCap":63630856},{"date":"2025-01-10","current":-0.745587,"twenty":-9.766379,"median":-6.668233,"eighty":-3.443141,"marketCap":63368218},{"date":"2025-01-17","current":-0.682185,"twenty":-9.757593,"median":-6.64746,"eighty":-3.394029,"marketCap":57979610},{"date":"2025-01-24","current":-0.777875,"twenty":-9.728647,"median":-6.634163,"eighty":-3.357836,"marketCap":66112333},{"date":"2025-01-31","current":-0.764235,"twenty":-9.679607,"median":-6.615947,"eighty":-3.33003,"marketCap":64953103},{"date":"2025-02-07","current":-0.728538,"twenty":-9.627716,"median":-6.602833,"eighty":-3.302322,"marketCap":61919181},{"date":"2025-02-14","current":-0.694653,"twenty":-9.575681,"median":-6.587368,"eighty":-3.285899,"marketCap":59039219},{"date":"2025-02-21","current":-0.790555,"twenty":-9.547301,"median":-6.571503,"eighty":-3.269086,"marketCap":67190054},{"date":"2025-02-28","current":-0.6288,"twenty":-9.504726,"median":-6.5445,"eighty":-3.25033,"marketCap":53442312},{"date":"2025-03-07","current":-0.659169,"twenty":-9.471913,"median":-6.535863,"eighty":-3.205797,"marketCap":56023410},{"date":"2025-03-14","current":-0.708434,"twenty":-9.46119,"median":-6.523067,"eighty":-3.172132,"marketCap":54251153},{"date":"2025-03-21","current":-0.730966,"twenty":-9.46119,"median":-6.505302,"eighty":-3.135359,"marketCap":55976617},{"date":"2025-03-28","current":-0.524344,"twenty":-9.45159,"median":-6.471711,"eighty":-3.095717,"marketCap":40153746},{"date":"2025-04-04","current":-0.50337,"twenty":-9.439312,"median":-6.424459,"eighty":-3.068441,"marketCap":38547597},{"date":"2025-04-11","current":-0.530456,"twenty":-9.431377,"median":-6.38555,"eighty":-3.053997,"marketCap":40621824},{"date":"2025-04-17","current":-0.574322,"twenty":-9.419093,"median":-6.347165,"eighty":-3.027788,"marketCap":43980972},{"date":"2025-04-25","current":-0.559101,"twenty":-9.384913,"median":-6.325743,"eighty":-2.990813,"marketCap":42815366},{"date":"2025-05-02","current":-0.567835,"twenty":-9.330001,"median":-6.290473,"eighty":-2.93622,"marketCap":43484231},{"date":"2025-05-09","current":-0.501308,"twenty":-9.305504,"median":-6.248269,"eighty":-2.852042,"marketCap":38389651},{"date":"2025-05-16","current":-0.899541,"twenty":-9.281378,"median":-6.196397,"eighty":-2.778275,"marketCap":59360719},{"date":"2025-05-23","current":-0.868986,"twenty":-9.266302,"median":-6.118024,"eighty":-2.732134,"marketCap":57344415},{"date":"2025-05-30","current":-0.763727,"twenty":-9.233944,"median":-6.06626,"eighty":-2.68702,"marketCap":50398342},{"date":"2025-06-06","current":-0.817828,"twenty":-9.165249,"median":-6.028618,"eighty":-2.612139,"marketCap":53968494},{"date":"2025-06-13","current":-0.944392,"twenty":-9.144284,"median":-5.995401,"eighty":-2.518608,"marketCap":62320431},{"date":"2025-06-20","current":-0.811241,"twenty":-9.06243,"median":-5.977628,"eighty":-2.425137,"marketCap":53533786},{"date":"2025-06-27","current":-0.816427,"twenty":-8.99924,"median":-5.954094,"eighty":-2.405095,"marketCap":53876003},{"date":"2025-07-03","current":-0.990504,"twenty":-8.97729,"median":-5.94435,"eighty":-2.294861,"marketCap":65363384},{"date":"2025-07-11","current":-1.222888,"twenty":-8.960121,"median":-5.929245,"eighty":-1.478825,"marketCap":80698391},{"date":"2025-07-18","current":-1.198641,"twenty":-8.960121,"median":-5.887193,"eighty":-1.452831,"marketCap":79098297},{"date":"2025-07-24","current":-0.987841,"twenty":-8.960121,"median":-5.850885,"eighty":-1.407789,"marketCap":65187651},{"date":"2025-08-01","current":-0.789096,"twenty":-8.963555,"median":-5.80983,"eighty":-1.382153,"marketCap":52072427},{"date":"2025-08-08","current":-0.856372,"twenty":-8.963555,"median":-5.794312,"eighty":-1.363672,"marketCap":56511994},{"date":"2025-08-15","current":-1.195298,"twenty":-8.963555,"median":-5.794312,"eighty":-1.34192,"marketCap":58091473},{"date":"2025-08-22","current":-1.115611,"twenty":-8.963555,"median":-5.724733,"eighty":-1.266932,"marketCap":54218708},{"date":"2025-08-29","current":-1.078683,"twenty":-8.963555,"median":-5.677369,"eighty":-1.252587,"marketCap":52424012},{"date":"2025-09-05","current":-1.002884,"twenty":-8.966989,"median":-5.644274,"eighty":-1.207787,"marketCap":48740162},{"date":"2025-09-12","current":-0.960125,"twenty":-8.963555,"median":-5.551394,"eighty":-1.192797,"marketCap":46662093},{"date":"2025-09-19","current":-0.785204,"twenty":-8.963555,"median":-5.43708,"eighty":-1.164025,"marketCap":38160902},{"date":"2025-09-26","current":-0.794922,"twenty":-8.963555,"median":-5.315424,"eighty":-1.147146,"marketCap":38633191},{"date":"2025-10-03","current":-0.882382,"twenty":-8.963555,"median":-5.196764,"eighty":-1.129391,"marketCap":42883786},{"date":"2025-10-10","current":-0.835737,"twenty":-8.963555,"median":-5.149792,"eighty":-1.086069,"marketCap":40616802},{"date":"2025-10-17","current":-0.822132,"twenty":-8.963555,"median":-5.045518,"eighty":-1.068425,"marketCap":39955598},{"date":"2025-10-24","current":-0.767712,"twenty":-8.963555,"median":-5.001691,"eighty":-1.020024,"marketCap":37310783},{"date":"2025-10-31","current":-0.686082,"twenty":-8.963555,"median":-4.951178,"eighty":-0.991856,"marketCap":33343561},{"date":"2025-11-07","current":-0.695799,"twenty":-8.963555,"median":-4.919271,"eighty":-0.979561,"marketCap":33815849},{"date":"2025-11-14","current":-0.752163,"twenty":-8.963555,"median":-4.842662,"eighty":-0.956119,"marketCap":36555122},{"date":"2025-11-21","current":-1.466516,"twenty":-8.963555,"median":-4.817569,"eighty":-0.95209,"marketCap":38149940},{"date":"2025-11-28","current":-3.319725,"twenty":-8.963555,"median":-4.80244,"eighty":-0.95209,"marketCap":86359318},{"date":"2025-12-05","current":-3.071657,"twenty":-8.963555,"median":-4.74296,"eighty":-0.95209,"marketCap":79906094},{"date":"2025-12-12","current":-5.101709,"twenty":-8.963555,"median":-4.74296,"eighty":-0.95209,"marketCap":132715846},{"date":"2025-12-19","current":-4.984922,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":129677772},{"date":"2025-12-26","current":-5.120148,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":133195542},{"date":"2026-01-02","current":-5.107855,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":132875744},{"date":"2026-01-09","current":-4.929603,"twenty":-8.963555,"median":-4.721194,"eighty":-0.95209,"marketCap":128238685},{"date":"2026-01-16","current":-4.677591,"twenty":-8.963555,"median":-4.689597,"eighty":-0.95209,"marketCap":121682842},{"date":"2026-01-23","current":-4.75135,"twenty":-8.963555,"median":-4.672184,"eighty":-0.95209,"marketCap":123601625},{"date":"2026-01-30","current":-4.431725,"twenty":-8.963555,"median":-4.620833,"eighty":-0.95209,"marketCap":115286897},{"date":"2026-02-06","current":-4.062927,"twenty":-8.890146,"median":-4.586033,"eighty":-0.95209,"marketCap":105692981},{"date":"2026-02-13","current":-3.41753,"twenty":-8.853649,"median":-4.558056,"eighty":-0.95209,"marketCap":88903627},{"date":"2026-02-20","current":-3.872381,"twenty":-8.809478,"median":-4.53834,"eighty":-0.95209,"marketCap":100736124},{"date":"2026-02-27","current":-3.36221,"twenty":-8.772232,"median":-4.509039,"eighty":-0.95209,"marketCap":87464539},{"date":"2026-03-06","current":-3.196251,"twenty":-8.752593,"median":-4.50135,"eighty":-0.95209,"marketCap":83147277},{"date":"2026-03-13","current":-5.906828,"twenty":-8.733384,"median":-4.497512,"eighty":-0.95209,"marketCap":105649533},{"date":"2026-03-20","current":-5.570667,"twenty":-8.700258,"median":-4.497512,"eighty":-0.95209,"marketCap":99636958},{"date":"2026-03-27","current":-4.216419,"twenty":-8.646402,"median":-4.476469,"eighty":-0.95209,"marketCap":75414870},{"date":"2026-04-02","current":-5.272925,"twenty":-8.605296,"median":-4.476124,"eighty":-0.95209,"marketCap":94311535},{"date":"2026-04-10","current":-5.599481,"twenty":-8.580897,"median":-4.476124,"eighty":-0.95209,"marketCap":100152322},{"date":"2026-04-17","current":-5.964456,"twenty":-8.548467,"median":-4.476124,"eighty":-0.95209,"marketCap":106680261},{"date":"2026-04-24","current":-6.233385,"twenty":-8.514027,"median":-4.476124,"eighty":-0.95209,"marketCap":111490321},{"date":"2026-05-01","current":-6.11813,"twenty":-8.450828,"median":-4.476124,"eighty":-0.95209,"marketCap":109428866},{"date":"2026-05-08","current":-7.91419,"twenty":-8.426164,"median":-4.476124,"eighty":-0.95209,"marketCap":141553196},{"date":"2026-05-15","current":-6.697664,"twenty":-8.371164,"median":-4.476124,"eighty":-0.95209,"marketCap":119392562},{"date":"2026-05-22","current":-5.685787,"twenty":-8.182917,"median":-4.476124,"eighty":-0.95209,"marketCap":101354837},{"date":"2026-05-29","current":-5.815885,"twenty":-8.098253,"median":-4.475807,"eighty":-0.951988,"marketCap":103673973},{"date":"2026-06-05","current":-5.92671,"twenty":-8.088406,"median":-4.476124,"eighty":-0.95209,"marketCap":105649533},{"date":"2026-06-12","current":-5.806248,"twenty":-8.041563,"median":-4.476124,"eighty":-0.95209,"marketCap":103502185},{"date":"2026-06-18","current":-5.618328,"twenty":-7.918173,"median":-4.476124,"eighty":-0.95209,"marketCap":100152322},{"date":"2026-06-26","current":-5.984532,"twenty":-7.815602,"median":-4.475807,"eighty":-0.951988,"marketCap":106680261},{"date":"2026-07-02","current":-5.724335,"twenty":-7.758463,"median":-4.475807,"eighty":-0.951988,"marketCap":102041988},{"date":"2026-07-10","current":-6.292913,"twenty":-7.627311,"median":-4.475807,"eighty":-0.951988,"marketCap":112177472},{"date":"2026-07-17","current":-5.358131,"twenty":-7.534311,"median":-4.475807,"eighty":-0.951988,"marketCap":95514050},{"date":"2026-07-24","current":-5.242488,"twenty":-7.476163,"median":-4.475807,"eighty":-0.951988,"marketCap":93452595},{"date":"2026-07-31","current":-5.069024,"twenty":-7.259771,"median":-4.473524,"eighty":-0.951885,"marketCap":90360414},{"date":"2026-08-07","current":-5.165393,"twenty":-7.174722,"median":-4.473524,"eighty":-0.951885,"marketCap":92078292},{"date":"2026-08-14","current":-2.677385,"twenty":-7.105408,"median":-4.452295,"eighty":-0.951885,"marketCap":83488899},{"date":"2026-08-21","current":-2.677385,"twenty":-7.056517,"median":-4.430467,"eighty":-0.951885,"marketCap":83488899},{"date":"2026-08-28","current":-2.793075,"twenty":-6.977428,"median":-4.399407,"eighty":-0.951885,"marketCap":87096445},{"date":"2026-09-04","current":-2.952836,"twenty":-6.892965,"median":-4.367559,"eighty":-0.951885,"marketCap":92078292},{"date":"2026-09-11","current":-2.726966,"twenty":-6.877417,"median":-4.344398,"eighty":-0.951885,"marketCap":85034990},{"date":"2026-09-18","current":-2.561696,"twenty":-6.821976,"median":-4.305994,"eighty":-0.951885,"marketCap":79881354},{"date":"2026-09-25","current":-2.401934,"twenty":-6.783486,"median":-4.28383,"eighty":-0.951885,"marketCap":74899506},{"date":"2026-09-30","current":-2.457024,"twenty":-6.765011,"median":-4.254247,"eighty":-0.951885,"marketCap":76617385}],"updateTime":1790853670518},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VRCA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655872964","title":"Verrica Pharmaceuticals Schedules Conference Call to Discuss Q2 Results, Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2655872964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655872964?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:08","pubTimestamp":1785413319,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals schedules conference call to discuss Q2 results, corporate updateVerrica schedules a conference call, webcast on Aug. 6, 2026 to report Q2 results ended June 30, 2026, issue a ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL6TN8S3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2095319765.USD","SG9999014021.USD","BCDF","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","BK4588","LU0314104364.USD","BK4585","VRCA","IE00BKPKM429.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014039.USD","BK4007","BK4112","IE00B64PRP62.GBP","LU2210149790.SGD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655874733","title":"Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2655874733","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655874733?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:00","pubTimestamp":1785412801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nTUA9HDKYB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272721","title":"Verrica Signs Exclusive Deal with Medomie to Market Ycanth in Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272721","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653272721?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:07","pubTimestamp":1784635664,"startTime":"0","endTime":"0","summary":"Verrica signs exclusive deal with Medomie to market Ycanth in IsraelVerrica Pharmaceuticals signed an exclusive distribution, marketing, supply deal with Medomie Pharma to commercialize YCANTH for mol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDLc0LkGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","SG9999014013.SGD","SG9999014039.USD","SG9999014021.USD","IE00BKPKM429.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK4585","LU2210150020.SGD","VRCA","BK4112","BK4007","BCDF","IE00B3QW5Z07.USD","BK4588","IE00B64PRP62.GBP","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653929272","title":"Verrica Pharmaceuticals: Granted Medomie Exclusive Right to Obtain & Maintain Marketing Authorizations for Ycanth in Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2653929272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653929272?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635209,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0IM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653905272","title":"Verrica Pharmaceuticals Inc: Eligible to Receive up to $8.2 Mln in Total Regulatory and Commercial Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2653905272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653905272?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635209,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0IM:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653729402","title":"Verrica Pharmaceuticals Inc: Will Receive 60% of Net Selling Price of Product Sold by Medomie in Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2653729402","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653729402?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635209,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0IM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272180","title":"Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize Ycanth® for the Treatment of Molluscum Contagiosum in Israel","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272180","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653272180?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:00","pubTimestamp":1784635209,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nFWN43N0IM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645883027","title":"Verrica Pharmaceuticals' Doses First US Patient in Phase 3 Trial Evaluating Ycanth to Treat Common Warts","url":"https://stock-news.laohu8.com/highlight/detail?id=2645883027","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645883027?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:50","pubTimestamp":1782132639,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals  said Monday that the first US patient has been dosed in the COVE-3 second clinical trial in its global phase 3 program evaluating Ycanth to treat common warts.The company said the trial is evaluating the efficacy and safety of Ycanth when applied once every 21 days for a up to four applications in patients aged two years and older.The COVE-2 study is enrolling patients in the US, the company said, while the COVE-3 study is enrolling patients in the US and Japan. Verrica also said that it and Torii intend to seek marketing approval for Ycanth in the US and Japan.The companies are equally bearing the costs of the global Phase 3 program, with Verrica funding the first $40 million of trial costs.Shares of Verrica Pharmaceuticals were down over 2% pre-bell.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645244340","title":"Verrica doses first US patient in pivotal Phase 3 COVE-3 trial of YCANTH for common warts","url":"https://stock-news.laohu8.com/highlight/detail?id=2645244340","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645244340?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:05","pubTimestamp":1782129925,"startTime":"0","endTime":"0","summary":"Results have not been presented; the trial is ongoing, with COVE-3 enrolling in the U.S. and Japan.The program aims to support U.S. and Japan marketing filings; YCANTH could become the first approved U.S. treatment for common warts.Phase 3 initiation followed earlier Phase 2 data that showed wart clearance in a meaningful share of treated patients, with expected local skin reactions.Torii will split global Phase 3 costs 50/50, funding the first $40 million, about 90% of the current trial budget.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL3Pc1hV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD","VRCA","SG9999014013.SGD","LU0314104364.USD","BK4112","NDAQ","IE00BN0W2V16.EUR","BK4007","BK4588","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","BK4585","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645024169","title":"Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (Cove-3) of Its Phase 3 Program Evaluating Ycanth® (Vp-102) for the Treatment of Common Warts","url":"https://stock-news.laohu8.com/highlight/detail?id=2645024169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645024169?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:05","pubTimestamp":1782129900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nTUA6QMHJH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642201454","title":"Verrica’s COVE-3 Wart Study Moves Forward, Offering a Small but Notable Catalyst for VRCA and VEEV","url":"https://stock-news.laohu8.com/highlight/detail?id=2642201454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642201454?lang=en_us&edition=fundamental","pubTime":"2026-06-11 00:33","pubTimestamp":1781109184,"startTime":"0","endTime":"0","summary":"Veeva Systems Inc ($VEEV), Verrica Pharmaceuticals ($VRCA) announced an update on their ongoing clinical study. COVE-3: A Phase 3, Double-blind, Ra...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/verricas-cove-3-wart-study-moves-forward-offering-a-small-but-notable-catalyst-for-vrca-and-veev?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/verricas-cove-3-wart-study-moves-forward-offering-a-small-but-notable-catalyst-for-vrca-and-veev?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","BK4585","LU0170899867.USD","LU0058720904.USD","VEEV","LU0266013472.USD","BK4528","VRCA","BK4588","BK4613","BK4504","LU1989764748.USD","LU1989764664.SGD","LU0289739699.SGD","BK4534","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642949205","title":"Verrica Pharmaceuticals shareholders approve amended 2018 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642949205","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642949205?lang=en_us&edition=fundamental","pubTime":"2026-06-10 04:06","pubTimestamp":1781035602,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals held its annual shareholder meeting on June 5, 2026.Shareholders adopted an amended and restated 2018 Equity Incentive Plan, effective immediately upon approval.Shareholders elected two director nominees to serve until the 2029 annual meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nNDL3TmWGl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638136516","title":"Verrica Pharmaceuticals Coverage Assumed by HC Wainwright & Co. at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2638136516","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638136516?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:01","pubTimestamp":1779793260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VRCA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 07:01 ET (11:01 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638513123","title":"Verrica Pharmaceuticals Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2638513123","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638513123?lang=en_us&edition=fundamental","pubTime":"2026-05-26 18:14","pubTimestamp":1779790492,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nFWN423097:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637809440","title":"Lytix Biopharma Q1 net loss widens to NOK 25.95 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637809440","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637809440?lang=en_us&edition=fundamental","pubTime":"2026-05-21 13:07","pubTimestamp":1779340065,"startTime":"0","endTime":"0","summary":"Lytix Biopharma posted a Q1 operating loss of NOK 26.8 million, widening from NOK 13.44 million a year earlier, while the period loss deepened to NOK 25.95 million from NOK 12.92 million.Total operating expenses climbed to NOK 26.8 million from NOK 13.44 million, due to higher direct R&D costs tied to the completion of the ATLAS-IT-05 study, strategic commercial assessments, and increased corporate activity.Cash and short-term financial investments totaled NOK 120 million at quarter-end following two Q1 capital raises with gross proceeds of NOK 77.3 million.Partner Verrica plans to start a Phase III registrational trial for VP-315  in basal cell carcinoma in 2026, while Lytix said it remains open for partnerships and is preparing LTX-401 for clinical entry in 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL493NNj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722499","title":"Verrica Pharmaceuticals (VRCA) Returns To Larger Q1 Loss Challenging Bullish Profitability Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722499","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635722499?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:50","pubTimestamp":1778799054,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals (VRCA) opened Q1 2026 with revenue of about US$5.0 million and a basic EPS loss of US$0.45, while trailing twelve month figures show revenue of US$37.2 million and a basic EPS loss of US$1.31. Over the past year, the company reported quarterly revenue moving from US$3.4 million in Q1 2025 to US$14.3 million in Q3 2025, then settling around the US$5.0 million mark in Q1 2026. EPS moved from a loss of US$1.03 to a small profit of US$0.02 in Q2 2025 before returning to...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrca/verrica-pharmaceuticals/news/verrica-pharmaceuticals-vrca-returns-to-larger-q1-loss-chall","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vrca/verrica-pharmaceuticals/news/verrica-pharmaceuticals-vrca-returns-to-larger-q1-loss-chall","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VRCA","BK4007","BLSX","BK4112","BLSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635228049","title":"Verrica Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635228049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635228049?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:02","pubTimestamp":1778619726,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryVerrica Pharmaceuticals Inc VRCA.OQ reported a quarterly adjusted loss of 41 cents per share for the quarte","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P37J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635477842","title":"Verrica Pharmaceuticals Q1 revenue rises on YCANTH demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2635477842","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635477842?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:12","pubTimestamp":1778616778,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Q1 revenue rises on YCANTH demandOverviewDermatology therapeutics firm's Q1 revenue rose 46% yr/yr on record demand for YCANTHAdjusted EPS loss widened yr/yr; no analyst consen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL1N41P1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635242041","title":"Verrica Q1 FY26 net loss flat at $9.7 million; revenue rises 46.1% YoY to $5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242041","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242041?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:02","pubTimestamp":1778616134,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals posted Q1 2026 net loss of $9.7 million, or $0.45 per share, versus net loss of $9.7 million, or $1.03 per share, a year earlier.Revenue climbed 46.1% year over year to $5 million, including U.S. YCANTH net product revenue of $4.3 million, up 25.4% year over year.YCANTH dispensed applicator units rose 51.3% year over year to 15,302, up 12.1% sequentially, passing 100,000 total units since launch.License and collaboration revenue was $733,000, driven primarily by commercial supply for partner Torii Pharmaceutical’s YCANTH launch in Japan.Management said it has surpassed 50% of current targeted enrollment in Phase 3 COVE-2 common warts trial, expecting to initiate second Phase 3 trial COVE-3 in mid-2026 with sites in US and Japan.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL9ZRkv8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","BK4007","IE00BN0W2T93.GBP","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4112","BK4585","IE00BKPKM429.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00B64PRP62.GBP","SG9999014005.SGD","BK4588","VRCA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635257242","title":"Verrica Pharmaceuticals Q1 Adj. EPS $(0.41) Misses $(0.38) Estimate, Sales $5.023M Beat $4.520M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635257242","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635257242?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:01","pubTimestamp":1778616111,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals (NASDAQ:VRCA) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.38) by 7.89 percent. This is a 53.41 percent increase over losses of $(0.88) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52505050/verrica-pharmaceuticals-q1-adj-eps-0-41-misses-0-38-estimate-sales-5-023m-beat-4-520m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Verrica Pharmaceuticals Q1 Adj. EPS $(0.41) Misses $(0.38) Estimate, Sales $5.023M Beat $4.520M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}